Correlation Between Acumen Pharmaceuticals and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Coya Therapeutics, Common, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Coya Therapeutics,.
Diversification Opportunities for Acumen Pharmaceuticals and Coya Therapeutics,
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acumen and Coya is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Coya Therapeutics,
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 1.21 times more return on investment than Coya Therapeutics,. However, Acumen Pharmaceuticals is 1.21 times more volatile than Coya Therapeutics, Common. It trades about -0.23 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about -0.29 per unit of risk. If you would invest 253.00 in Acumen Pharmaceuticals on September 14, 2024 and sell it today you would lose (51.00) from holding Acumen Pharmaceuticals or give up 20.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Coya Therapeutics, Common
Performance |
Timeline |
Acumen Pharmaceuticals |
Coya Therapeutics, Common |
Acumen Pharmaceuticals and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Coya Therapeutics,
The main advantage of trading using opposite Acumen Pharmaceuticals and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.Acumen Pharmaceuticals vs. Puma Biotechnology | Acumen Pharmaceuticals vs. Iovance Biotherapeutics | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Inozyme Pharma |
Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |